Salem Investment Counselors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55.1M Sell
154,723
-24,185
-14% -$7.78M 1.37% 16
2026
Q2
$86.4M Sell
178,908
-6,000
-3% -$1.59M 2.14% 13
2026
Q1
$20.3M Buy
184,908
+2,583
+1% +$368K 0.59% 33
2025
Q4
$30.3M Sell
182,325
-1,403
-0.8% -$235K 0.86% 23
2025
Q3
$36M Buy
183,728
+7,884
+4% +$1.3M 1.03% 19
2025
Q2
$15.9M Buy
+175,844
New +$13.9M 0.5% 41

Other funds holding ALAB

Salem Investment Counselors's ALAB Position: Q3 2026 in Review

Salem Investment Counselors reduced its Astera Labs (ALAB) stake by 14% in Q3 2026, selling an estimated $7.78M and leaving 154,723 shares worth $55.1M. The position accounts for 1.37% of the portfolio, ranked #16.

Salem Investment Counselors first reported a position in ALAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $86.4M in Q2 2026. 93 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Salem Investment Counselors held 154,723 shares of Astera Labs worth $55.1M as of Q3 2026.
  • Salem Investment Counselors sold 24,185 Astera Labs shares in Q3 2026, an estimated $7.78M.
  • Astera Labs made up 1.37% of Salem Investment Counselors's portfolio in Q3 2026, its #16 holding.
  • Salem Investment Counselors first reported a position in Astera Labs in Q2 2025 and has held it in 6 quarters since.
  • Salem Investment Counselors's Astera Labs position peaked at $86.4M in Q2 2026.
  • 93 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.